Literature DB >> 6175532

Detection of luxol-fast-blue positive cells in human promyelocytic leukemia cell line HL-60.

L Lu, H E Broxmeyer, L M Pelus, M Andreeff, M A Moore.   

Abstract

Differentiation of HL-60 cells toward the eosinophilic series has not been reported previously. Eosinophil granule specific staining with Luxol-fast-blue was used to determine if HL-60 cells could differentiate into the eosinophilic lineage. The specificity of the Luxol-fast-blue stain for cells of the eosinophilic series was substantiated by comparison of the staining of cells from a patient with an eosinophilic syndrome by Wright-Giemsa and Luxol-fast-blue. Luxol-fast-blue positivity was most notable in cells found in colonies formed from HL-60 clonogenic cells in semisolid agar medium. Colony and cluster formation was spontaneous but in the presence of medium conditioned by either human placental cells or the human monocyte-like cell line, GCT, Luxol-fast-blue positive colonies and clusters were detected at a higher frequency.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6175532

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  3 in total

1.  Optimization of nb-4 and hl-60 differentiation for use in opsonophagocytosis assays.

Authors:  Roland A Fleck; Harpinder Athwal; Jane A Bygraves; David J Hockley; Ian M Feavers; Glyn N Stacey
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 May-Jun       Impact factor: 2.416

2.  Characterization of interleukin 5 receptors on eosinophilic sublines from human promyelocytic leukemia (HL-60) cells.

Authors:  G Plaetinck; J Van der Heyden; J Tavernier; I Faché; T Tuypens; S Fischkoff; W Fiers; R Devos
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

3.  Eosinophilic differentiation of the human promyelocytic leukemia cell line, HL-60.

Authors:  S A Fischkoff; A Pollak; G J Gleich; J R Testa; S Misawa; T J Reber
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.